News

International Stem Cell has launched fifteen new human cell culture products into the commercial research markets over the last twelve months through its wholly-owned subsidiary, Lifeline Cell Technology.

SAFC Pharma has completed the addition to its Carlsbad, California facility that expands the company’s contract manufacturing services for its late phase and commercial clients. The $12m project

Aquilent has been selected by the Department of Veterans Affairs (VA) for two health IT support contracts valued around $2.7m. Under the terms of the contracts, Aquilent is

Nobilon, the human vaccine business unit of Schering-Plough has initiated a clinical Proof of Concept trial with SCH 900795, a new intranasal Live Attenuated Influenza Vaccine (LAIV) for

ICON has strengthened its Bioanalytical Sciences team following the acquisitions of Prevalere Life Sciences (Prevalere) and Veeda Laboratories (Veeda) with the appointment of Dr. Ray Briggs as vice

Shire, the Irish drugmaker, has settled patent lawsuits with Novartis’ Sandoz unit that was attempting to market a generic version of its attention deficit hyperactivity disorder drug (ADHD)

Caleco Pharma (Caleco) has initiated the clinical studies of Lamiridosin in collaboration with Puleva Biotech (Puleva) to evaluate the effectiveness of Lamiridosin, a dietary supplement that the company

Antisoma has reported that its aptamer drug AS1411 has been granted orphan drug status in both the US and the EU for the treatment of acute myeloid leukaemia

The company claims that these kits are the latest additions to the Applied Biosystems leading-edge portfolio of validated human identification workflow solutions, including genetic analyzers, reagent kits, PCR